iNova appointment
September 9, 2010
WILL Delaat has been appointed
as a new non-executive director at
iNova Pharmaceuticals, effective
immediately.
Currently the Independent
Chairman of Medicines Australia,
Delaat has 40 years worth of
pharmaceutical industry experience
under his belt including a previous
position as managing director of
Merck Sharp & Dohme Australia/NZ.
Delaat also currently holds a nonexecutive
directorship with
Pharmaxis, and is the chairman of
the Pharmaceuticals Industry
Council.
“Will brings with him extensive
experience in growing successful
pharmaceutical companies and his
insight into the trends and future
outlook of the industry makes him a
very valuable addition to our
Board,” said Paul Evans, Chairman
of iNova.
“Over the past three years iNova
has grown into a very significant
Australian pharmaceutical
company which can now benefit
from Will’s contribution as we move
to our next phase of growth,” he
added.
Expressing his excitement over his
new appointment Delaat said “I
am passionate about the Australian
pharmaceutical industry so I am
very pleased to accept this
appointment to the iNova Board
and provide my experience to this
exciting and growing Australian
company.”
The above article was sent to subscribers in Pharmacy Daily's issue from 09 Sep 10To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Sep 10
